But when the researchers analyzed the data, they found that fluoxetine appeared not to provide meaningful benefits for ...
Treatment takes about 20 minutes, with the majority focusing on the left side of the brain to help with depression and a few ...
Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for ...
Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to difficulties in academic and professional life but also as a major cause of suicide in ...
Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...
The FDA has granted 510(k) clearance and a label expansion for a transcranial magnetic stimulation device to treat patients ...
Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...
Postpartum depression descended on Kristina Leos like a heavy fog that separated her from everyone she loved. She could see ...
Researchers at Emory University have discovered that a drug called infliximab might improve motivation in people with depression, especially those with high levels of inflammation in their bodies.
Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in ...
Despite the advice of two of the most successful pop anthems of the last two decades, when it comes to depression, no one can ...
A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results